Literature DB >> 4063808

Cell proliferation after ischemic infarction in gerbil brain.

M Du Bois, P D Bowman, G W Goldstein.   

Abstract

In order to study cell proliferation after ischemic infarction, a model of bilateral common carotid artery occlusion in the gerbil was developed. A comparison of survival rates after 15, 30, 45 and 60 min of occlusion revealed that 45 min was the maximum duration of ischemia after which most (72%) of the gerbils were alive at 1 week. The administration of pentobarbital (single dose, 30 mg/kg) postoperatively to badly seizing animals increased survival to 100%. Large, well-demarcated infarcts were present in posterior thalamus or midbrain in 62% of gerbils subjected to 45 min bilateral occlusion. In 60% of these animals the infarcts were unilateral; in 40% they were bilateral. To quantitate cell proliferation in the infarcts from 12 h to 25 days after ischemia, gerbils were injected with [3H]thymidine 4 h prior to sacrifice, and autoradiographs were prepared from sectioned brains. Proliferation took place from 2 to 7 days after occlusion, with a maximum of 24% labeled cells at 6 days.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063808     DOI: 10.1016/0006-8993(85)90183-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Hippocampal neurons transplanted into ischemically lesioned hippocampus: anatomical assessment of survival, maturation and integration.

Authors:  L A Mudrick; K G Baimbridge
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Cell proliferation after ischemic injury in gerbil brain. An immunocytochemical and autoradiographic study.

Authors:  M du Bois; P D Bowman; G W Goldstein
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

3.  Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia.

Authors:  H S Mickel; O Kempski; G Feuerstein; J E Parisi; H D Webster
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.